Drug intelligence / Profile preview

UROLITINN

Development stage
Unknown
Lead developer
INNventa Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

UROLITINN is a herbal dietary supplement developed by INNventa Pharm for the prevention and treatment of urolithiasis (kidney stones) and various urinary tract conditions. It is a complex botanical formulation obtained through the hydrodistillation of eight medicinal plants: *Equisetum arvense* (horsetail), *Spergularia rubra* (red sandwort), *Peumus boldus* (boldo leaf), *Opuntia ficus-indica* (Indian fig flower), *Sideritis angustifolia* (mountain tea), *Rosmarinus officinalis* (rosemary), *Cynodon dactylon* (Bermuda grass rhizome), and *Melissa officinalis* (lemon balm). The product acts synergistically to stimulate diuresis, facilitating the removal of salt crystals and stones from the urinary tract, while also providing antispasmodic and analgesic effects to control pain. It is indicated for urolithiasis, urinary tract infections (such as cystitis, urethritis, and pyelonephritis), and symptoms like dysuria, polyuria, nocturia, and urinary incontinence. The product is marketed as an oral solution and has a reported history of use spanning over 90 years.

Brand names
UROLITINNUROLIT INN
Other names
urolithin

Beyond the preview

Go deeper on UROLITINN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UROLITINN.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call